e.g Cystic Fibrosis, Ataxia, ALS, CDKL5 or Multiple Myeloma
Rareomics automatically finds new research articles that mention hundreds of different rare diseases.
We create a news feed for each rare disease where you can read and search abstracts of the latest papers. You can also see statistics on the most mentioned genes, drugs and other terms.
You can follow a disease to add it to your own news feed, and choose to receive email alerts so you never miss the latest research.
Rare diseases mentioned in most papers in the last 30 days
Rareomics automatically searches for hundreds of rare diseases in all journal article abstracts added to PubMed every day. We use text mining to identify diseases, genes, species and thousands of other scientific terms.
Scientific terms are often complicated and have many different variations. Rareomics automatically searches for many different names to try to match a disease, for example it knows that 'Tuberous Sclerosis' may be called 'Sclerosis Tuberosa' or 'Bourneville Disease'. Whichever name the paper authors used you will still see the article.
Rareomics understands hierarchies in disease names, and uses relationships to find additional matches. So if you follow 'Motor Neuron Disease' you automatically see mentions of 'Amyotrophic Lateral Sclerosis', 'Progressive Bulbar Palsy' and other specific types of the disease.
We use the terms we've identified to show summaries and statistics for each rare disease, for example you can see which genes are most frequently mentioned in papers or the names of authors who publish most often.
Rareomics is a free website created by Healx, a social venture based in Cambridge, UK. Healx combine significant drug repurposing expertise with data mining and state-of-the-art machine learning to find existing drugs that could treat rare diseases.
At Healx we work with rare disease patient groups and charities to offer affordable access to the latest drug repurposing technology. We also work with biotechnology and pharmaceutical companies to help them find new uses for their compounds in rare diseases.
If you'd like to find out more please get in touch: email@example.com.